Innovating Works

NB

Desconocido
APPROACH: Applied Public-Private Research enabling OsteoArthritis Clinical Headway NORDIC BIOSCIENCE COMPOUND DEVELOPMENT AS participó en un FP6: The problem: finding the right patient for the right treatmentDespite a large and growing disease burden in osteoarthritis (OA), many pharma...
2015-06-01 - 2020-11-30 | Financiado
IDEAL: Integrated research on DEvelopmental determinants of Aging and Longevity NORDIC BIOSCIENCE COMPOUND DEVELOPMENT AS participó en un FP7: IDEAL will obtain insight into the role of early life conditions affecting late-life health, disease and aging, and the role of epigenetic r...
Financiado
EUROCLAST: Exploring Functional and Developmental Osteoclast Heterogeneity in Health and Disease NORDIC BIOSCIENCE COMPOUND DEVELOPMENT AS participó en un FP7: Euroclast proposes a research training program on osteoclast biology in the context of osteoclast-driven diseases. Osteoclasts are the compl...
Financiado
EURHEALTHAGEING: European ResearcH on DevElopmentAL BirtH and Genetic Determinants of Ageing NORDIC BIOSCIENCE COMPOUND DEVELOPMENT AS participó en un FP7: Developmental plasticity modulated by epigenetic processes such as methylation and post-translational modifications is influenced by early l...
Financiado
DEVELOPAKURE: Clinical Development of Nitisinone for Alkaptonuria NORDIC BIOSCIENCE COMPOUND DEVELOPMENT AS participó en un FP7: DevelopAKUre is a proposal to fund the clinical development of an orphan designated drug, nitisinone, for the treatment of a rare Mendelian...
Financiado
APPROACH: Applied Public Private Research enabling OsteoArthritis Clinical Headway NORDIC BIOSCIENCE COMPOUND DEVELOPMENT AS participó en un FP7: The problem: finding the right patient for the right treatment Despite a large and growing disease burden in osteoarthritis (OA), many pharm...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.